Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failur
| Image |  |
|---|---|
| Description | scientific article published on 28 December 2019 |
| Author/s |
author: Fabien B Vincent Bridget-Anne Kirwan Jarosław Drożdż Gerasimos Filippatos Marco Metra Ewa A Jankowska Theresa A McDonagh Stefan D Anker Frank Ruschitzka Domingo Pascual-Figal Davor Milicic Irakli Khintibidze Piotr Ponikowski Hadi Skouri Alexandra Maria Dorobanțu Marcus Andreas Ohlsson Hans Kragten |
| Publication date | December 28, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |